Advertisement
Singapore markets closed
  • Straits Times Index

    3,460.82
    -0.34 (-0.01%)
     
  • S&P 500

    5,478.02
    -77.72 (-1.40%)
     
  • Dow

    40,005.18
    -352.91 (-0.87%)
     
  • Nasdaq

    17,640.15
    -357.21 (-1.98%)
     
  • Bitcoin USD

    66,789.46
    -34.55 (-0.05%)
     
  • CMC Crypto 200

    1,371.89
    +5.99 (+0.44%)
     
  • FTSE 100

    8,146.29
    -21.08 (-0.26%)
     
  • Gold

    2,424.10
    +16.80 (+0.70%)
     
  • Crude Oil

    77.38
    +0.42 (+0.55%)
     
  • 10-Yr Bond

    4.2350
    -0.0040 (-0.09%)
     
  • Nikkei

    39,154.85
    -439.54 (-1.11%)
     
  • Hang Seng

    17,311.05
    -158.31 (-0.91%)
     
  • FTSE Bursa Malaysia

    1,621.14
    -8.54 (-0.52%)
     
  • Jakarta Composite Index

    7,262.76
    -51.10 (-0.70%)
     
  • PSE Index

    6,753.12
    0.00 (0.00%)
     

Vastned Belgium: Application of article 7:97 BCAC by the Board of Directors of Vastned Belgium

Vastned Belgium
Vastned Belgium

The board of directors of Vastned Belgium NV (Euronext: VASTB, “Vastned Belgium” or the “Company”) has requested the committee of independent directors of the Company (the “Committee”) to issue an opinion in application of article 7:97 of the Belgian Companies and Associations Code (the “BCAC”) on the adoption of common draft terms of the cross-border merger (the 
“Merger Proposal”) between the Company and Vastned Retail N.V, a listed public limited liability company incorporated under Dutch law, having its corporate seat in Amsterdam, the Netherlands, and its principal place of business at Mercuriusplein 11, 2132 HA Hoofddorp, the Netherlands and registered in the trade register of the Dutch Chamber of Commerce (Kamer van Koophandel) under number 24262564 (“Vastned Retail” and together with the Company, the “Parties” and, together with their affiliated companies, the “Group”).

Full press release:

Attachment